As of 10:30 AM on the 9th, Celltrion is trading at 351,000 KRW, up 0.29% from the previous day. This marks a 22.73% increase compared to November 17. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have a tentative net purchase of 6,000 shares of Celltrion, while institutions have a net sale of 2,000 shares. Over the past five days, individual investors have net sold 65,206 shares, while foreigners and institutions have net bought 401,460 shares and net sold 282,553 shares, respectively.


On December 4, Celltrion was a market topic with the headline "Short covering begins... Merrill Lynch buys 200,000 shares."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing